AWM
ABBV icon

Angeles Wealth Management’s AbbVie ABBV Stock Holding History

Angeles Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.9M Buy
23,439
+2,664
+13% +$573K 0.27% 41
2026
Q1 		$4.52M Buy
20,775
+412
+2% +$91.4K 0.25% 43
2025
Q4 		$4.65M Buy
20,363
+5,477
+37% +$1.25M 0.26% 41
2025
Q3 		$3.45M Buy
14,886
+448
+3% +$91.2K 0.21% 47
2025
Q2 		$2.68M Sell
14,438
-479
-3% -$89K 0.18% 48
2025
Q1 		$3.13M Buy
14,917
+649
+5% +$126K 0.26% 42
2024
Q4 		$2.54M Buy
14,268
+1,201
+9% +$221K 0.21% 45
2024
Q3 		$2.58M Buy
13,067
+507
+4% +$94.6K 0.22% 42
2024
Q2 		$2.15M Buy
12,560
+2,850
+29% +$472K 0.2% 45
2024
Q1 		$1.77M Buy
9,710
+939
+11% +$162K 0.18% 48
2023
Q4 		$1.36M Buy
8,771
+2,507
+40% +$365K 0.17% 53
2023
Q3 		$934K Buy
6,264
+191
+3% +$28K 0.13% 65
2023
Q2 		$818K Sell
6,073
-226
-4% -$33.1K 0.11% 81
2023
Q1 		$1M Buy
6,299
+381
+6% +$58.2K 0.15% 69
2022
Q4 		$956K Buy
5,918
+821
+16% +$126K 0.17% 71
2022
Q3 		$684K Buy
5,097
+1,261
+33% +$181K 0.14% 78
2022
Q2 		$588K Sell
3,836
-16
-0.4% -$2.44K 0.12% 91
2022
Q1 		$624K Buy
+3,852
New +$560K 0.12% 93

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Angeles Wealth Management's ABBV Position: Q2 2026 in Review

Angeles Wealth Management increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $573K and bringing the position to 23,439 shares worth $5.9M. The position accounts for 0.27% of the portfolio, ranked #41.

Angeles Wealth Management first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Angeles Wealth Management held 23,439 shares of AbbVie worth $5.9M as of Q2 2026.
  • Angeles Wealth Management bought 2,664 AbbVie shares in Q2 2026, an estimated $573K.
  • AbbVie made up 0.27% of Angeles Wealth Management's portfolio in Q2 2026, its #41 holding.
  • Angeles Wealth Management first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.